Damoiseaux J, Csernok E, Rasmussen N, et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofuorescence (IIF) versus antigen-specifc immunoassays. Ann Rheum Dis 2017;76:647-53.
Damoiseaux J, Csernok E, Rasmussen N, et al. Antineutrophil cytoplasmic antibodies: appropriate use and interpretation. Ann Rheum Dis 2017;76:e24.
Damoiseaux J, Csernok E, Rasmussen N, et al. Antineutrophil cytoplasmic antibodies: reporting and diagnostic strategies. Ann Rheum Dis 2017;76:e39.
Savige J, Gillis D, Benson E, et al. International consensus statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
Csernok E, Damoiseaux J, Rasmussen N, et al. Evaluation of automated multi-parametric indirect immunofuorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Autoimmun Rev 2016;15:736-41.
Bossuyt X, Cohen Tervaert JW, Arimura Y, et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017;13:683-92.
Bossuyt X, Rasmussen N, Van Paassen P, et al. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Rheumatology 2017;56:1533-41.
